Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bilateral Nasal Polyposis”

13 trials

Showing 13 of 13 results

Testing effectiveness (Phase 2)Study completedNCT01362244
What this trial is testing

Mepolizumab in Nasal Polyposis

Who this might be right for
Nasal Polyps
GlaxoSmithKline 109
Large-scale testing (Phase 3)Study completedNCT01622569
What this trial is testing

Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi Directional Device in Subjects With Bilateral Nasal Polyposis Followed by an 8-Week Open-Label Extension Phase to Assess Safety

Who this might be right for
Bilateral Nasal Polyposis
Optinose US Inc. 323
Not applicableStudy completedNCT02559284
What this trial is testing

RESPIMER® Netiflow® vs. Saline Solutions During Nasal Irrigation Following Bilateral Ethmoidectomy (Nasal Polyposis)

Who this might be right for
Polyp of Ethmoidal SinusSurgery
Laboratoire de la Mer 189
Testing effectiveness (Phase 2)Study completedNCT01393340
What this trial is testing

Clinical and Biological Effects of Anti-IgE (Omalizumab) in Patients With Bilateral Nasal Polyposis and Asthma

Who this might be right for
Nasal PolyposisAsthma
University Hospital, Ghent 23
Large-scale testing (Phase 3)Study completedNCT03085797
What this trial is testing

Effect of Mepolizumab in Severe Bilateral Nasal Polyps

Who this might be right for
Nasal Polyps
GlaxoSmithKline 414
Large-scale testing (Phase 3)Study completedNCT02898454
What this trial is testing

Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps

Who this might be right for
Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)
Sanofi 448
Not applicableStudy completedNCT02427503
What this trial is testing

ATP Project (Asthma afTer Polypectomy)

Who this might be right for
AsthmaNasal Polyps
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 106
Testing effectiveness (Phase 2)Study completedNCT01920893
What this trial is testing

An Evaluation of Dupilumab in Patients With Nasal Polyposis And Chronic Symptoms Of Sinusitis

Who this might be right for
Nasal Polyps
Sanofi 60
Large-scale testing (Phase 3)Study completedNCT03591068
What this trial is testing

Efficacy & Safety of OPN-375 Adults With Bilateral Nasal Polyps Using Nasoendoscopic Video

Who this might be right for
Nasal Polyposis
Optinose US Inc. 11
Testing effectiveness (Phase 2)Study completedNCT03688555
What this trial is testing

Evaluate the Effect of ACT-774312 in Subjects With Bilateral Nasal Polyposis

Who this might be right for
Bilateral Nasal Polyposis
Idorsia Pharmaceuticals Ltd. 10
Large-scale testing (Phase 3)Study completedNCT02912468
What this trial is testing

A Controlled Clinical Study of Dupilumab in Patients With Bilateral Nasal Polyps

Who this might be right for
Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)
Sanofi 276
Large-scale testing (Phase 3)Study completedNCT01624662
What this trial is testing

Efficacy and Safety Study of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Using a Novel Bi-directional Device

Who this might be right for
Bilateral Nasal Polyposis
Optinose US Inc. 323
Large-scale testing (Phase 3)Active Not RecruitingNCT03747458
What this trial is testing

OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps

Who this might be right for
Bilateral Nasal Polyposis
Optinose US Inc. 72

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation